TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: anxiety on a subscale of the GHQ-28
Endpoint domain: Adverse events/effects
Primary endpoint: continence rates at 3, 6, and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: potency rates at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's component from Dublin
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Social interactions from SAQLI
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mean moxifloxacin levels in the anterior chamber
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ratio of aqueous to serum moxifloxacin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory Protection (RP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of intraoperative seizures
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in kyphosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in sitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sputum conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage area of capsule cover
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Students' motivation to subspecialize in sports medicine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Students' involvement in sports trauma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for practical-oriented education
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Successful identification of sentinel lymph nodes (SLN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive outcome (IQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: DAS28 score at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age-disparate relationships
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of partners
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Cumulative resort to morphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to first bolus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-HDL-C decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: oxidized LDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of EUS for predicting tumor invasion depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: improvement in alertness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: decrease in agitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: improvement in cognitive recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average medical cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of malignancies found
Endpoint domain: Adverse events/effects
Primary endpoint: mindfulness and mindful eating scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TR displacement greater than 0.3 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rotation greater than 1.5°
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discussion about CRC screening
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: CRC screening test ordered
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean number of urge incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean urinary frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma LDL cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall plasma cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall plasma lathosterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vaccine failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in CMI response towards anergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Development of HLA antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: Alcohol-related cardiomyopathy diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Impact on decision-making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Approval rating from participants
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient access to care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: complete recovery at three months postcollision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of progression based on aortic diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cocaine use problem severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: employment problem severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAR scores deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irregularity Index difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort and appearance preference
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinically relevant mistakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall performance median percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities of daily living (ADL) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rates after 5 years
Endpoint domain: Mortality/survival
Primary endpoint: total combined effectiveness rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: secondary infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence or degree of mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: WHO 3/4 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of TGF-beta(2) administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Complete radiographic healing of periapical lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of closed fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: endurance shuttle walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Respiratory disease Questionnaire‐Dyspnoea (CRQ‐D)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total esophageal acid exposure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total number of acid and weakly acidic reflux episodes per 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean LES resting and relaxation nadir pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Average duration of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Streptococcal sequelae
Endpoint domain: Adverse events/effects
Primary endpoint: Radial artery occlusion (RAO) rate at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Composite safety endpoint (spontaneous intestinal perforation, surgical necrotising enterocolitis, or death)
Endpoint domain: Adverse events/effects
Primary endpoint: Perceived risk of Alzheimer's Disease (AD)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Belief in preventability of Alzheimer's Disease (AD)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Engagement in preventive behaviors for Alzheimer's Disease (AD)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain freedom rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Most bothersome symptom (MBS)-free rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of correct steps remembered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death or chronic lung disease at 28 days
Endpoint domain: Mortality/survival
Primary endpoint: Overjet decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grip relaxation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NFCS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death due to colorectal cancer (CRC)
Endpoint domain: Mortality/survival
Primary endpoint: e-health acceptance behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: trunk extension movement flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in BMI z score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of flow‐mediated dilatation (%FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24 h ambulatory blood pressure monitoring (ABPM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Enjoyment of the kiosk
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preference for learning with the kiosk
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Interest in learning about other topics using IMM
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean proportion of bifidobacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stool mean pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: handheld ultrasound machine runtime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to full recovery
Endpoint domain: Life impact
Endpoint subdomain: Return to work
Primary endpoint: foot contact area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: center of pressure trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: foot pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematuria
Endpoint domain: Adverse events/effects
Primary endpoint: Circulatory collapse
Endpoint domain: Adverse events/effects
Primary endpoint: IIEF-Q3 scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: IIEF-Q4 scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: HSCRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Impact of diabetes on life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean baseline-adjusted VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 physical component scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: worst level of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: current feeling of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: healing rates of reflux esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gross motor function classification system improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait symmetry improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in knowledge of EBM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impairment in Perceptual Speed (Identical Pictures task)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Delayed recall of prose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in moderate/severe discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in severe discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Baroreflex control of heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Muscle sympathetic nerve activity (MSNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure (BP) response to phenylephrine and nitroprusside
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Return rate for subsequent mammograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain as most bothersome symptom
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tiredness as most bothersome symptom
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Appetite as most severe symptom
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Noninducibility at the end of the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Elimination of untolerated VTs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total procedural and fluoroscopy times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accuracy of BrST in differential diagnosis of SPN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PBLAC score <= 75
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety self-rating scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Heart rate stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Survival at 100 days
Endpoint domain: Mortality/survival
Primary endpoint: Survival at 180 days
Endpoint domain: Mortality/survival
Primary endpoint: Branched chain amino acids (BCAA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Various metabolites levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: C4/Ci4, C3, C5 acylcarnitines levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Treatment Satisfaction (TS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: American College of Rheumatology (ACR) response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events resulting in treatment withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in bacterial culture rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of incidents with a mental health tag applied
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obstetrical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-m acceleration time improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 15-m mean running velocity time improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reactive strength gain (contact time depth jump)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in costs associated with ESRD
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Calcium levels post-thyroidectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PTH concentrations post-thyroidectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Need for calcium supplements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Opioid consumption (OEC) during the first 3 postoperative days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) for pain scores during the first 24 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perioperative time consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Use of dust masks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of respirators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Current smoking
Endpoint domain: Adverse events/effects
Primary endpoint: Serum total testosterone and free testosterone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement in total IIEF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in erectile function
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Mean aqueous humor concentration of moxifloxacin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of proteins C and S
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Activated protein C inhibitor complexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Activated protein C-alpha1-antitrypsin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of PRAE
Endpoint domain: Adverse events/effects
Primary endpoint: Attendance in treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of drug abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV risk behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: long-term morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neurological development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change in stroke volume (%deltaSV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: side‐effects and non‐compliance
Endpoint domain: Adverse events/effects
Primary endpoint: Arterial PCO2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tonometric PCO2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of illicit opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of sPD‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of sPD‐L1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volumes of feed administered in the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numbers of painful episodes
Endpoint domain: Adverse events/effects
Primary endpoint: neural respiratory drive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Upper dermatome blocked to cold sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper dermatome blocked to light touch sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean epidural space pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of pregnancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of parturitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Detection of neonatal hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5STS time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemodynamic responses during anaesthesia induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FEV1 recovery to pre-exposure values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Viewing time
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning